Cargando…
Prolonged Hypoglycemic Effect Due to Intentional Massive Insulin Glargine Overdose
Introduction: Since its discovery in 1921, insulin has served as the mainstay of treatment for patients with both type 1 and insulin-dependent type 2 diabetes mellitus (T2DM). Insulin is available in both long and short acting formulations. Glargine, a long-acting insulin, has an onset of action in...
Autores principales: | Gill, Kirit S, Arao, Kevin A, Merolli, Alisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266136/ http://dx.doi.org/10.1210/jendso/bvab048.805 |
Ejemplares similares
-
SUN-160 Insulin Glargine Time of Injection during Fasting Ramadan in Patients with Type 1 Diabetes
por: Alamoudi, Reem, et al.
Publicado: (2019) -
MON-620 Ademolus Hypoglycemic Index
por: Ademolu, Adegbenga Bolanle
Publicado: (2020) -
SUN-171 Glargine Use in a Neonatal Diabetic
por: Sandhu, Sanjeet, et al.
Publicado: (2019) -
MON-689 Diabetes Mellitus---Hypoglycemic Response---Empyema
por: Chen, Yaning
Publicado: (2020) -
SUN-179 Prolonged Hypoglycemia from Insulin Degludec
por: Kothari, Vallari, et al.
Publicado: (2019)